Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease

Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative disease that is a terminal form of dementia with an alarming spread rate. The treatment of AD usually involves symptomatic therapy, but the research field for new medicines to correct AD focus on the pathogenetic keys of the disease, i.e., a mitochondr...

Full description

Saved in:
Bibliographic Details
Main Authors: D. I. Pozdnyakov, A. A. Vikhor, V. M. Rukovitsina, E. T. Oganesyan
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2024-01-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
alzheimer’s disease
mitochondrial dysfunction
curcumin analogues
neuroprotection
Online Access:https://www.pharmpharm.ru/jour/article/view/1399
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items